MY ACCOUNT | NEWSLETTER |

AMR: Animal vaccines to exceed $15B


The global market for animal vaccines is forecast to grow at a CAGR of 5.2% during the forecast period of 2021 to 2030, according to a recent report by Allied Market Research, a market analysis company. The uptick is anticipated to lead the market, valued in 2020 at $9.09 billion, to reach an estimate of $15.20 billion by 2030, according to AMR. 

The forecasted growth is pinned on the expectation that the increased spending in animal health, rates of pet ownership, rates of purchase of companion animal health insurance, and increased rates of animal disease will continue. Adding to that, investment in vaccines and hybrid animals are predicted to continue to boost the market. On the other hand, prices in milk and meat and adverse effects of vaccines may slow growth. 

After breaking down the market report by segment, attenuated vaccines are expected to retain a lead in the market into 2030 after garnering 2/5 of the market in 2020. Despite its stronghold, DNA-based vaccines are forecast to grow at the fastest rate, with a CAGR of 8.1%. 

By type of animal, livestock will maintain its lead in the market out of 2020 and into 2030, according to the report based on better knowledge about the importance of vaccinating livestock and the increased rate of disease. In contrast, the segment for companion animals is expected to grow at a CAGR of 5.5% based on higher rates of disease and higher rates of spending. 

When looking at the market by geographic region, North America held the largest share in 2020 (2/5) and is expected to keep its lead as the infrastructure is established in the region. 


Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Advancing the 3Rs: innovation, implementation, ethics and society

Like0
Dislike0

Automated Knowledge-Based Radiation Treatment Planning in Canine and Feline Nasal Tumors

Like0
Dislike0

Does Lung Function Imaging Modality Have a Dosimetric Impact On Functional Avoidance Treatment Planning: Assessment Using Prospective Clinical Trial Data

Like0
Dislike0

One Committed and Caring NC State Veterinary Student, So Many Choices

Like0
Dislike0

Dentalis Earns 5 VOHC® Seals, Positioning for Global Expansion in Animal Health

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top